These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9797226)

  • 21. Molecular epidemiology of Neisseria gonorrhoeae exhibiting decreased susceptibility and resistance to ciprofloxacin in Hawaii, 1991-1999.
    Trees DL; Sandul AL; Neal SW; Higa H; Knapp JS
    Sex Transm Dis; 2001 Jun; 28(6):309-14. PubMed ID: 11403186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.
    Shigemura K; Shirakawa T; Okada H; Hinata N; Acharya B; Kinoshita S; Kofuku T; Kawabata M; Kamidono S; Arakawa S; Gotoh A
    Sex Transm Dis; 2004 Mar; 31(3):180-4. PubMed ID: 15076932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent.
    Dillon JA; Li H; Sealy J; Ruben M; Prabhakar P;
    Sex Transm Dis; 2001 Sep; 28(9):508-14. PubMed ID: 11518867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India.
    Chaudhry U; Ray K; Bala M; Saluja D
    Sex Transm Infect; 2002 Dec; 78(6):440-4. PubMed ID: 12473806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.
    Belland RJ; Morrison SG; Ison C; Huang WM
    Mol Microbiol; 1994 Oct; 14(2):371-80. PubMed ID: 7830580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trend of ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Italy and analysis of the molecular determinants.
    Starnino S; Dal Conte I; Matteelli A; Galluppi E; Cusini M; Di Carlo A; Delmonte S; Stefanelli P
    Diagn Microbiol Infect Dis; 2010 Aug; 67(4):350-4. PubMed ID: 20638603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Ezaki T; Saito I; Kawada Y
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1020-3. PubMed ID: 8849219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.
    Ruiz J; Marco F; Sierra JM; Aguilar L; Garcia-Mendez E; Mensa J; Jiménez De Anta MT; Vila J
    Int J Antimicrob Agents; 2003 Jul; 22(1):73-6. PubMed ID: 12842332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluoroquinolone treatment failure in gonorrhea. Emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinolones.
    Deguchi T; Saito I; Tanaka M; Sato K; Deguchi K; Yasuda M; Nakano M; Nishino Y; Kanematsu E; Ozeki S; Kawada Y
    Sex Transm Dis; 1997 May; 24(5):247-50. PubMed ID: 9153731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial susceptibilities and plasmid contents of Neisseria gonorrhoeae isolates from commercial sex workers in Dhaka, Bangladesh: emergence of high-level resistance to ciprofloxacin.
    Bhuiyan BU; Rahman M; Miah MR; Nahar S; Islam N; Ahmed M; Rahman KM; Albert MJ
    J Clin Microbiol; 1999 Apr; 37(4):1130-6. PubMed ID: 10074537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinolone resistance-determining region mutations and por type of Neisseria gonorrhoeae isolates: resistance surveillance and typing by molecular methodologies.
    Giles JA; Falconio J; Yuenger JD; Zenilman JM; Dan M; Bash MC
    J Infect Dis; 2004 Jun; 189(11):2085-93. PubMed ID: 15143477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
    Gootz TD; Zaniewski RP; Haskell SL; Kaczmarek FS; Maurice AE
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Bangladesh (1997 to 1999): rapid shift to fluoroquinolone resistance.
    Rahman M; Sultan Z; Monira S; Alam A; Nessa K; Islam S; Nahar S; Shama-A-Waris ; Alam Khan S; Bogaerts J; Islam N; Albert J
    J Clin Microbiol; 2002 Jun; 40(6):2037-40. PubMed ID: 12037060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiclonal increase in ciprofloxacin-resistant Neisseria gonorrhoeae, Thailand, 1998-1999.
    Trees DL; Sirivongrangson P; Schultz AJ; Buatiang A; Neal SW; Knapp JS; Kilmarx PH
    Sex Transm Dis; 2002 Nov; 29(11):668-73. PubMed ID: 12438903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibilities of Neisseria gonorrhoeae isolates containing amino acid substitutions in GyrA, with or without substitutions in ParC, to newer fluoroquinolones and other antibiotics.
    Tanaka M; Nakayama H; Haraoka M; Saika T; Kobayashi I; Naito S
    Antimicrob Agents Chemother; 2000 Jan; 44(1):192-5. PubMed ID: 10602748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial activity of a new fluoroquinolone, DU-6859a, against quinolone-resistant clinical isolates of Neisseria gonorrhoeae with genetic alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV.
    Deguchi T; Yasuda M; Nakano M; Kanematsu E; Ozeki S; Ishihara S; Saito I; Kawada Y
    J Antimicrob Chemother; 1997 Feb; 39(2):247-9. PubMed ID: 9069547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Neisseria gonorrhoeae strains with decreased susceptibility to fluoroquinolones isolated in Greece from 1996 to 1999.
    Mavroidi A; Tzouvelekis LS; Tassios PT; Flemetakis A; Daniilidou M; Tzelepi E
    J Clin Microbiol; 2000 Sep; 38(9):3489-91. PubMed ID: 10970412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.